Gross Margin

A new Southern California distribution deal for an FDA-cleared nerve ablation system could revolutionize treatment for trigeminal neuralgia, but risks remain.

As personalized therapies fragment drug production into small batches, a new flexible dispensing system aims to eliminate bioprocessing's costly QC bottlenecks.

As freight broker margins compress to 14.7% on flat demand, a landmark $604 million jury verdict threatens the survival of mid-market logistics intermediaries.

As it pivots to an "AI-forward" future, Health Catalyst faces significant revenue headwinds. Can new board member Tami Reller provide the needed stability?

On its 35th anniversary, Hunt Brothers Pizza hit 11,000 locations. Their secret? A disruptive 'no-fee' model that empowers local stores and reshapes an industry.

A stunning $1M profit in 4.5 months on a new acquisition isn't just a number. It's a challenge to the entire 'growth-at-all-costs' tech ethos.

As Centuri Holdings prepares for a key investor conference, its new leadership team must address pressing margin concerns while pitching a long-term growth story.

Macy's reports impressive growth and raises guidance, but a one-time tariff refund inflates profits, leaving investors questioning the true strength of its turnaround.

The firm’s upcoming Town Hall reveals more than strong Q2 growth; it showcases a deliberate strategy to dominate the future of equitable, AI-assisted care.

Cognyte's stellar earnings reveal more than just profit. They signal a successful pivot to a high-margin, software-first model in the high-stakes world of national security.

With 227% H1 revenue growth and a pivotal acquisition, Rapid Nutrition leverages AI and data to pivot from product seller to a vertically integrated platform.

Amid industry headwinds, Hooker Furnishings' consistent dividend signals financial stability. But does it reflect true momentum or just a resilient balance sheet?

China's economic recovery is being written at the checkout counter. Cautious but savvy consumers are forcing a retail revolution, prioritizing value and speed.

A return to Q4 profitability, fueled by a direct-to-consumer surge and a key education deal, reveals Koss's new playbook for growth and diversification.

A new report reveals 330x markups and sweeping Chinese regulations are turning the humble syringe into the new frontier of profit, risk, and power in aesthetics.

Covalon's record quarter wasn't just a fluke. It's a story of strategic execution, massive margin expansion, and a product that redefines patient safety.

As JinkoSolar names investment strategist Wei 'Dimi' Du its new CEO, the move signals a sharp focus on financial discipline amid mounting market pressures.

Amid housing market headwinds, Atlas Engineered Products posts a strong rebound, betting its future on a robotic factory and a strategy to rebuild the supply chain.

As AOUT prepares its Q1 FY27 report, investors look past the numbers to see if its diverse brand strategy can navigate market headwinds and deliver on growth.

BTCS reports a 61% gross margin thanks to its Imperium DeFi unit, but a $35M net loss tells a different story. A deep dive into a high-stakes commercialization play.